Instituto Mário Penna
Instituto Mário Penna is a Brazilian non-profit oncology hospital founded in 1963 and headquartered in Belo Horizonte, providing cancer diagnosis and treatment services across the Minas Gerais region with a sizable specialty clinical workforce.
- Company typePrivate
- Founded1963
- HeadquartersBelo Horizonte, Brazil
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What Instituto Mário Penna does
Instituto Mário Penna is a Brazilian non-profit healthcare institution founded in 1963 and headquartered in Belo Horizonte, Minas Gerais. The organization specializes in cancer treatment, positioning it as a dedicated oncology provider within the regional health system. Its scale is substantial for a specialty non-profit, with reported headcount in the 1,001-5,000 range — indicating a multi-departmental hospital operation likely combining inpatient, outpatient, surgical, radiotherapy, chemotherapy, and diagnostic imaging capabilities typical of a comprehensive cancer center.
The institution's revenue mechanics for a Brazilian philanthropic oncology hospital typically rest on three pillars: reimbursement through the Sistema Único de Saúde (SUS, Brazil's public health system), private health-insurance and convênio billings, and donations/fundraising from individuals, corporations, and events (a common channel for entities of this type in Brazil). Pricing transparency is not disclosed in the available source material; the canonical web property (mariopenna.org.br) returned only a loader/verification page during data collection, so product mix, technology stack, partnerships, and operational details could not be verified from first-party content.
No information was available regarding recent strategic moves, leadership changes, funding rounds, capital expenditures, technology partnerships, or expansion initiatives. Given the data gap, this description is limited to verifiable firmographics; any operational or financial claims beyond founding year, location, specialty, scale, and non-profit status would be unsupported by the input.
Instituto Mário Penna firmographics
Firmographics- Name
- Instituto Mário Penna
- Website
- https://mariopenna.org.br
- Company type
- Private
- Founded year
- 1963
- Headcount range
- 1,001–5,000 employees
- Short description
- Instituto Mário Penna is a Brazilian non-profit oncology hospital founded in 1963 and headquartered in Belo Horizonte, providing cancer diagnosis and treatment services across the Minas Gerais region with a sizable specialty clinical workforce.
- Ownership category
- akta.pro rank
Instituto Mário Penna industry classification
Industry- Product category
- Oncology Hospital Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
- akta.pro primary industry
- Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)
- akta.pro secondary industry
- Digestive Oncology (GI Cancer Care) (HLAKAEAF)
Keywords
Where Instituto Mário Penna is headquartered
LocationHeadquarters
- HQ city
- Belo Horizonte
- HQ country
- Brazil
- HQ region
- Latin America
Markets served
Instituto Mário Penna business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain
Instituto Mário Penna product offering
Product offeringCore offering
Instituto Mário Penna is a non-profit health institution founded in 1963 that specializes in cancer treatments. It operates as a hospital/care facility providing oncology diagnostics, treatment, and patient care services to individuals with cancer in Brazil, headquartered in Belo Horizonte.
Differentiator
Problem solved
Functional benefit
Companies that use Instituto Mário Penna
Customer profileIdeal customer profiles1 record
Instituto Mário Penna technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Instituto Mário Penna partnerships and signals
Strategic signalRecent moves2 records
Instituto Mário Penna competitors and assessment
Company assessmentRegional players
- Hospital Felício Rocho: Large Belo Horizonte-based private hospital complex with oncology services. Comparable as a local competitor in the same city, drawing on the same patient pool and medical workforce.
- Hospital das Clínicas da UFMG: Large public academic hospital affiliated with the Federal University of Minas Gerais in Belo Horizonte. Comparable as a SUS-funded, university-affiliated provider of complex oncology care in the same city.
- Hospital Santa Casa BH: Historic non-profit hospital in Belo Horizonte providing oncology and complex care to SUS patients. Comparable as a fellow non-profit, SUS-dependent institution operating in the same metropolitan market.
Direct peers
- A.C. Camargo Cancer Center: One of Brazil's largest dedicated cancer hospitals based in São Paulo. Directly comparable to Instituto Mário Penna as a non-profit oncology specialty institution offering multidisciplinary cancer treatment, research, and teaching.
- Hospital de Câncer de Barretos (Fundação Pio XII): Major non-profit cancer hospital in Barretos, São Paulo state. Directly comparable in mission, scale, and SUS-dependent funding model, serving a large regional catchment across Brazil's oncology population.
Emerging players
- Grupo Oncologia D'Or: Network of oncology hospitals integrated into the Rede D'Or group. Comparable as a private, well-capitalized cancer care provider expanding across Brazil with stronger capex capacity.
- Oncoclínicas do Brasil: Brazil's largest oncology clinic network, offering outpatient chemotherapy, radiotherapy, and diagnostics across multiple states. Comparable as a direct competitor for outpatient oncology volume and physician recruitment in Minas Gerais.
Broad incumbents
- Hospital Israelita Albert Einstein: Large Brazilian private hospital system with significant oncology service lines. Comparable as a high-end hospital competitor in Minas Gerais/São Paulo corridors but broader in scope and private-pay oriented.
- Hospital Sírio-Libanês: Premium Brazilian private hospital with a strong oncology program and research institute. Comparable as a high-complexity oncology provider competing for the same specialist talent and complex-case referrals.
- MD Anderson Cancer Center: Global benchmark for dedicated non-profit cancer hospitals. Comparable as a reference point for specialty cancer hospital scale, research orientation, and outcomes-driven model, though operating in a different healthcare system.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks4 records
Key highlights4 records
Customer concentration
Instituto Mário Penna social profiles
Digital presenceInstituto Mário Penna financial estimates
Financial estimateRevenue estimate
Valuation estimate
Instituto Mário Penna leadership team
Management profileNumber of profiles
Instituto Mário Penna funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Instituto Mário Penna M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Instituto Mário Penna
What does Instituto Mário Penna do?
Instituto Mário Penna is a non-profit health institution founded in 1963 that specializes in cancer treatments. It operates as a hospital/care facility providing oncology diagnostics, treatment, and patient care services to individuals with cancer in Brazil, headquartered in Belo Horizonte.
When was Instituto Mário Penna founded?
Instituto Mário Penna was founded in 1963. It employs 1,001 to 5,000 people.
Where is Instituto Mário Penna based?
Instituto Mário Penna is headquartered in Belo Horizonte, Brazil, in the Latin America region.
Who are Instituto Mário Penna's main competitors?
Regional players on record are Hospital Felício Rocho, Hospital das Clínicas da UFMG and Hospital Santa Casa BH. Direct peers are A.C. Camargo Cancer Center and Hospital de Câncer de Barretos (Fundação Pio XII). Emerging players are Grupo Oncologia D'Or and Oncoclínicas do Brasil. Broad incumbents are Hospital Israelita Albert Einstein, Hospital Sírio-Libanês and MD Anderson Cancer Center.
Does Instituto Mário Penna have an API?
No public API is recorded for Instituto Mário Penna.
What industry is Instituto Mário Penna in?
Instituto Mário Penna's product category is Oncology Hospital Services. Its primary akta.pro industry code is HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs), with a secondary code of HLAKAEAF, Digestive Oncology (GI Cancer Care). Its NAICS code is 622310.